Related references
Note: Only part of the references are listed.Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Causing Invasive Pneumococcal Disease in Korea Between 2017 and 2019 After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine
Gyu Ri Kim et al.
ANNALS OF LABORATORY MEDICINE (2023)
Emergence of a multidrug-resistant and virulent Streptococcus pneumoniae lineage mediates serotype replacement after PCV13: an international whole-genome sequencing study
Stephanie W. Lo et al.
LANCET MICROBE (2022)
Effect of pneumococcal conjugate vaccines and SARS-CoV-2 on antimicrobial resistance and the emergence of Streptococcus pneumoniae serotypes with reduced susceptibility in Spain, 2004-20: a national surveillance study
Julio Sempere et al.
LANCET MICROBE (2022)
Invasive pneumococcal disease incidence in children and adults in France during the pneumococcal conjugate vaccine era: an interrupted time-series analysis of data from a 17-year national prospective surveillance study
Naim Ouldali et al.
LANCET INFECTIOUS DISEASES (2021)
Serotype distribution and clinical characteristics associated withstreptococcus pneumoniaeamong Chinese children and adults with invasive pneumococcal disease: a multicenter observational study
Ma-Chao Li et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)